INMB NASDAQ
Credit Risk of going bust: lower than 53% of companies Debt: 3.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down 99.5%), INmune Bio, Inc. would be worth roughly what it owes.
Total debt $1.4M against a stock market value of $42.2M.
Distance to default 5.45 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $702K (short-term plus half of long-term), stock volatility 72.7%; Altman Z'' -23.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Boca Raton, FL 33432
US
INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies. Its primary objective is to harness the body's innate immune system to combat various illnesses. The company is actively engaged in developing and bringing to market therapeutic candidates designed to address a spectrum of conditions such as blood cancers, solid tumors, and chronic inflammatory diseases. Its pipeline features key development programs including: INKmune: Aimed at treating women suffering from relapsed or refractory ovarian carcinoma and individuals diagnosed with high-risk myelodysplastic syndrome. INB03: An immunotherapy targeting patients with both hematologic malignancies and solid tumors. XPro1595: Under development for the treatment of Alzheimer's disease. INmune Bio holds licensing agreements with entities including Xencor, Inc., Immune Ventures, LLC, the University of Pittsburgh, and University College London. Established in 2015, INmune Bio is headquartered in Boca Raton, Florida.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Clark Ronnie Duane | A-Award | 100,000 | $2.33 | 2026-09-15 |
| SAPIRSTEIN JAMES | A-Award | 100,000 | $2.33 | 2026-09-15 |
| Clark Ronnie Duane | 0 | — | 2026-09-08 | |
| SAPIRSTEIN JAMES | 0 | — | 2026-09-08 | |
| Juda Scott | M-Exempt | 14,801 | $1.40 | 2026-07-02 |